2024-04-12 08:30:02 ET
Historical Analyst Recommendations
Latest 10 recommendations... Full story available on KlickAnalytics.com
2024-04-12 08:30:02 ET
Market Wire News is a media platform, the information on this page was provided by KlickAnalytics via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
NEW HAVEN, Conn., April 24, 2024 (GLOBE NEWSWIRE) -- Arvinas, Inc. (NASDAQ:ARVN), a clinical-stage biotechnology company creating a new class of...
NEW HAVEN, Conn., April 24, 2024 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced the appointment of Randy Teel, Ph.D., to the newly created role of Chief Business Officer....
2024-04-12 08:30:02 ET H.C. Wainwright analyst issues BUY recommendation for ARVN on April 12, 2024 06:52AM ET. The previous analyst recommendation was Buy. ARVN was trading at $37.26 at issue of the analyst recommendation. The overall analyst consensus : BUY. Curren...